Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BBH vs. IBB: which is better?

Bottom line

BBH vs IBB: the short answer

BBH (VanEck Biotech ETF) and IBB (iShares Biotechnology ETF) share a meaningful slice of their top holdings — about 66% by weight.

But IBB is far broader, holding 254 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.

BBH is cheaper at 0.35% vs 0.44% — a difference of $9.00 a year per $10,000 invested.

Over five years, BBH returned +2.7% a year vs +2.5% for IBB.

Updated Nov 19, 2026

BBH vs IBB side by side

BBHIBB
TypeETFETF
Fund familyVanEckiShares
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%0.44%
Annual cost per $10k$35$44
10-yr cost on $10k (prospectus)$443$555
Max front loadNoneNone
12b-1 fee—0%
1-yr return+21.2%+28.0%
5-yr return (annualized)+2.7%+2.5%
10-yr return (annualized)+4.5%+4.4%
Best quarter+27.6%+26.8%
Worst quarter−18.2%−22.9%
Net assets (fund)$395.6M$5.9B
Number of holdings25254
Portfolio turnover19%27%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearBBHIBBDifference
2025+21.2%+28.0%−6.9%
2024−4.4%−2.4%−2.0%
2023+3.9%+3.6%+0.2%
2022−15.1%−13.6%−1.5%
2021+11.8%+1.0%+10.8%
2020+22.1%+25.9%−3.9%
2019+25.8%+24.8%+1.0%
2018−10.2%−9.1%−1.1%
2017+16.6%+21.2%−4.6%
2016−15.0%−21.5%+6.5%

Source: Fund prospectus bar charts

Holdings overlap

17 of BBH's top 25 holdings also appear in IBB's top 25.

Shared top holdings
HoldingBBHIBB
Amgen Inc15.25%7.50%
Gilead Sciences Inc12.79%7.52%
Vertex Pharmaceuticals Inc9.10%7.66%
Regeneron Pharmaceuticals Inc6.21%5.70%
Argenx SE4.97%3.15%
Natera Inc4.92%2.11%
IQVIA Holdings Inc4.31%3.18%
Alnylam Pharmaceuticals Inc3.83%5.68%
Biogen Inc3.63%2.03%
Moderna Inc3.36%0.88%
Illumina Inc3.17%1.41%
United Therapeutics Corp2.83%1.82%
BeOne Medicines Ltd2.81%2.11%
Insmed Inc2.67%2.95%
Incyte Corp2.49%1.62%

Source: SEC Form N-PORT

BBH top 10

  1. Amgen Inc — 15.25%
  2. Gilead Sciences Inc — 12.79%
  3. Vertex Pharmaceuticals Inc — 9.10%
  4. Regeneron Pharmaceuticals Inc — 6.21%
  5. Revolution Medicines Inc — 5.27%
  6. Argenx SE — 4.97%
  7. Natera Inc — 4.92%
  8. IQVIA Holdings Inc — 4.31%
  9. Alnylam Pharmaceuticals Inc — 3.83%
  10. Biogen Inc — 3.63%

IBB top 10

  1. BlackRock Funds III — 13.18%
  2. Vertex Pharmaceuticals, Inc. — 7.66%
  3. Gilead Sciences, Inc. — 7.52%
  4. Amgen, Inc. — 7.50%
  5. Regeneron Pharmaceuticals, Inc. — 5.70%
  6. Alnylam Pharmaceuticals, Inc. — 5.68%
  7. IQVIA Holdings, Inc. — 3.18%
  8. Argenx SE — 3.15%
  9. Insmed, Inc. — 2.95%
  10. Mettler-Toledo International, Inc. — 2.49%

FAQ

What is the difference between BBH and IBB?
BBH (VanEck Biotech ETF) and IBB (iShares Biotechnology ETF) share a meaningful slice of their top holdings — about 66% by weight. But IBB is far broader, holding 254 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.
Which is cheaper, BBH or IBB?
BBH has the lower expense ratio (0.35%).
Should I own both BBH and IBB?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.